Neurons of the peripheral nervous system have long been known to require survival factors to prevent their death during development. But why they selectively become dependent on secretory molecules has remained a mystery, as is the observation that in the central nervous system, most neurons do not show this dependency. Using engineered embryonic stem cells, we show here that the neurotrophin receptors TrkA and TrkC (tropomyosin receptor kinase A and C, also known as Ntrk1 and Ntrk3, respectively) instruct developing neurons to die, both in vitro and in vivo. By contrast, TrkB (also known as Ntrk2), a closely related receptor primarily expressed in the central nervous system, does not. These results indicate that TrkA and TrkC behave as dependence receptors, explaining why developing sympathetic and sensory neurons become trophic-factor-dependent for survival. We suggest that the expansion of the Trk gene family that accompanied the segregation of the peripheral from the central nervous system generated a novel mechanism of cell number control.
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Neurotrophins and their receptors are components of a signalling system known to play major and diverse roles in the nervous system of vertebrates, ranging from the control of cell death to memory retention 1 . Decades of work with avian and rodent embryos have clarified some of the basic functions of the neurotrophins, such as the ability of target-derived nerve growth factor (NGF) to regulate the survival of neurons in the peripheral nervous system, including most sympathetic and sensory neurons 1 . Currently, the prevention of developmental cell death is explained by the ability of neurotrophins to activate specific tyrosine kinase receptors when axon terminals begin innervating their target tissues [2] [3] [4] [5] . Although this has been firmly established in the peripheral nervous system, it turned out that most neurons in the central nervous system (CNS) do not depend on neurotrophins or other diffusible growth factors for survival, even though naturally occurring cell death at the time of target innervation is a feature of both the peripheral nervous system and the CNS 6 . Brain-derived neurotrophic factor (BDNF) is the most widely expressed neurotrophin in the CNS, but its elimination fails to affect neuronal numbers in most CNS areas, even several weeks after birth 7, 8 . The neurotrophins bind and activate one of three tyrosine kinase receptors identified in mammals and primarily expressed by neurons 9 . They are designated TrkA, B and C, are highly related and seem to have evolved from an ancestral gene by domain and exon shuffling. A single trk gene of hitherto unknown function has been identified in the amphioxus Branchiostoma floridae 10 and the absence of any bona fide trk gene in Caenorhabditis elegans or Drosophila melanogaster, and of forward genetics in general, has critically hampered progress in the understanding of neurotrophin receptor signalling. Although TrkA, B and C are thought to transduce similar functions following neurotrophin binding 9 , it has been essentially impossible to test this assumption rigorously, as acute transfection of neurons with the corresponding complementary DNAs leads to expression levels that are difficult to control and typically leads to receptor auto-activation 11 . To circumvent these difficulties, we used a novel in vitro assay based on the neuronal differentiation of mouse embryonic stem (ES) cells 12, 13 engineered to express the three Trk receptors. These ES cells were also used to test and compare the in vivo impact of the forced expression of these receptors in all developing neurons.
TrkA and TrkC trigger cell death, TrkB does not
The neuron-specific microtubule-associated protein tau (Mapt) locus was targeted in ES cells 14 with cDNAs encoding rat TrkA, TrkB or TrkC with or without a haemagglutinin (HA) epitope used as a tag inserted at their amino-terminals to facilitate quantification of expression levels 15 . In most experiments, the second Mapt allele was also targeted with a green fluorescent protein (GFP) cDNA. Detailed examination of neurons derived from ES cells with or without targeted Mapt alleles failed to reveal any differences with regard to speed of differentiation, rate or pattern of outgrowth or cell survival. These engineered ES cells were differentiated using a protocol resulting in the generation of virtually pure progenitors expressing Pax6, a transcription factor instructing them to synchronously differentiate into glutamatergic neurons 13, 16 . The Mapt locus begins to be expressed when progenitors exit the cell cycle 14, 17 and quantification of the three receptors using HA antibodies indicated indistinguishable levels of expression (Fig. 1a, b) . TrkB under the control of its endogenous promoter begins to be detectably expressed only later in this ES-cell-based system 13 (see also Fig. 1c) . Unexpectedly, we found that neurons expressing TrkA and TrkC all died between 4 and 6 days in vitro (Fig. 1d, e) . Identical results were obtained with tagged and untagged TrkA and TrkC receptors, and the death of neurons could be prevented by the addition of NGF or neurotrophin-3 (NT3), respectively (Fig. 1d, e) . By contrast, TrkBexpressing neurons did not die (Fig. 1d) . This was not due to endogenous BDNF, as the addition of a BDNF blocking antibody or of the kinase inhibitor K252a did not cause any detectable effects (Supplementary Fig. 1 ). In line with our results with TrkC, a previous report indicated that acute expression of TrkC in 293 cells leads to increased levels of cell death, suggesting that it is a dependence receptor, a notion also tested and verified with NT3-dependent sensory neurons 18 . However, the same study failed to reach similar conclusions with TrkA 18 , presumably owing to uncontrolled levels of expression and receptor autoactivation 11 . Like several previous reports on the mechanism of action of dependence receptors 19 , this study also focused on the caspase-dependent proteolysis of the receptor as the mechanism causing cell death 18 . But in lysates of ES-cell-derived neurons, TrkA or TrkC proteolytic fragments were not detected, even in the presence of proteasome inhibitors. By contrast, proteolysis of the neurotrophin receptor p75 was observed in these same lysates, including the intracellular domain previously reported to be involved neuronal death 20 . This intracellular domain was only observed in the TrkA and TrkC in the absence of NGF or NT3, and inhibiting c-secretase activity with LY411575 blocked both the generation of this domain and of cell death ( Supplementary Fig. 2 ).
Embryos generated from Mapt::Trk ES cells To test the relevance of these in vitro findings in the context of the developing nervous system, we next used the so-called tetraploid complementation system to generate embryos entirely derived from mouse ES cells 21 . These cells expressed TrkA, TrkB or TrkC and GFP from the Mapt locus, thus allowing a comprehensive visualization of the nervous system 22 . ES cells expressing GFP from both Mapt alleles were used as control. At embryonic day 11.5 (E11.5), no overt differences were seen between the four genotypes examined, indicating that the initial steps of neurogenesis proceeded normally. In particular, peripheral ganglia could readily be observed in all four cases (Fig. 2) . However, a widespread and massive loss of the GFP signal was observed 2 days later in TrkA-and TrkC-expressing embryos, while those expressing only GFP or TrkB appeared identical and normal (Fig. 2) . Immunohistochemistry confirmed that at E13.5, most neurons were eliminated in both TrkA-and TrkC-expressing embryos (Fig. 3a) . It also revealed higher than normal levels of cell death at E11.5 in the spinal cord and dorsal root ganglia (DRG), in spite of the normal appearance of the embryos (Fig. 3b) . These findings indicate that the death-inducing function of TrkA and TrkC has the potential to eliminate essentially all developing neurons, regardless of their identity and developmental history. We also quantified the levels of Trk receptor expression in embryos derived from TrkA-ES cells, and found them to be higher than normal throughout the nervous system, including the DRG (Fig. 3c) . The lack of any cell death with TrkB is of special interest, as it is expressed by most neurons in the CNS, much more widely than TrkA, and at higher levels than TrkC ( Supplementary Fig. 3 and ref. 23 ). Immunoprecipitation of E13 brain and spinal cord lysates with TrkB-or TrkC-specific antibodies followed by western blot detection with pan-Trk antibodies confirmed that TrkB is expressed at considerably higher levels than TrkC in the developing CNS (data not shown). We also noted that, unlike in the CNS, rare DRG neurons escaped cell death at E13.5 (Fig. 3a, arrows) , presumably corresponding to those coming into contact with sufficient quantities of the corresponding neurotrophin. These results indicate that just as neurons can escape normally occurring cell death when NGF levels are artificially increased during development 24 , TrkA or TrkC expression beyond physiological levels also causes their death.
Survival of neurons lacking TrkA
To test the prediction that Trk expression is involved in the elimination of neural-crest-derived neurons during development, we focused our analyses on TrkA neurons, as TrkC is expressed by many progenitors already during their migration 25 . This complicates the analysis, as NT3 affects early aspects of gangliogenesis, before target-derived NT3-dependency for survival 26 . Sympathetic neurons were isolated from the superior cervical ganglion (SCG) of mice lacking TrkA 27 at E17 when many neurons begin to depend on target-derived NGF for survival 28 .
Whereas wild-type neurons were rapidly eliminated in the absence of NGF, those lacking TrkA survived in large numbers (Fig. 4a, b) . However, their processes were not maintained, and the addition of NGF caused their rapid death (Fig. 4a, c) . Previous work by others has indicated that the survival of sympathetic neurons and their axons is regulated by neurotrophin activation of p75, such that the activitydependent-release of BDNF causes axon pruning during development 29 .
In line with this, exuberant innervation of some target tissues innervated by sympathetic axons has been reported in animals lacking p75 (ref. 30) , as well as higher numbers of neurons in their SCG at birth, but not at E16.5 (ref. 31 ). To test if p75 expression accounts for the elimination of neurons lacking TrkA upon NGF addition, we isolated SCG neurons lacking both TrkA and p75 (ref. 32 ) and found that they survived and elongated processes both in the presence of NGF and in its absence (Fig. 4a-c) . Neurons lacking only p75 did not survive in large numbers in the absence of NGF (20.3 6 2.5% s.e.m., P , 0.05 compared with wild type), suggesting that at E17, molecules other than p75 may also be involved in TrkA-mediated killing. We next quantified cell death in DRG, another neural-crest-derived structure containing a high proportion of TrkA-expressing neurons 33 . At E11.5, in DRG lacking TrkA, the levels of cell death were not different from control, in line with a previous report 34 . However, cell death was significantly increased at E11.5 in Ngf 2/2 animals, confirming NGF-dependency for survival at this early age 35 ( Fig. 5a, b) . As DRG neurons lacking TrkA were previously reported to die at later time points 34 , we examined sections of mutants lacking both TrkA and p75, as there is a marked developmental increase of p75 expression in developing DRG 36 . We found the levels of cell death to be significantly reduced at E14.5 in animals lacking both neurotrophin receptors (Fig. 5) . As a control, TrkA 2/2 animals were also analysed at E10.5 and as expected, no differences were found between control and mutant ganglia ( Supplementary Fig. 4 ). At this developmental age, TrkA levels are still very low and NGF-dependency for survival insignificant 36 .
Cell death without Trk kinase activation
We next sought to determine whether death mediated by TrkA and TrkC requires activation of their kinase domain. Western blot experiments with antibodies against phosphotyrosine failed to reveal autoactivation, likewise with TrkB. Phosphorylation was only observed after addition of NGF, NT3 or BDNF to TrkA-, TrkC-or TrkBexpressing neurons, respectively (data not shown). Although the addition of K252a completely prevented Trk phosphorylation and the survival of TrkA-or TrkC-expressing neurons promoted by NGF or NT3, it did not prevent neuronal death in the absence of neurotrophin (Fig. 6a, b) , nor did it recognizably affect TrkB-expressing neurons ( Supplementary Fig. 1 ). In line with the notion that the death caused by TrkA and TrkC does not involve activation of their kinase domain, neurons generated from ES cells expressing a kinaseinactive mutant of TrkA (K538A; ref. 37) died just like those expressing wild-type TrkA (Fig. 6c-e) . As expected, these neurons could not be rescued by the addition of NGF (Fig. 6c, d ). In view of the results obtained with sympathetic and sensory neurons lacking p75, we examined its possible involvement in the death of ES-cell-derived neurons expressing TrkA. ES-cell-derived progenitors express p75 at relatively high levels 13 , and we previously showed that its moderate overexpression is sufficient to cause the death of neurons and of their processes 14 . TrkA ES cells were selected to also express one of three different short hairpin RNAs (shRNAs) efficiently targeting p75 N 5 5, mean 6 s.e.m., t-test, P value relative to wild-type). Scale bars: 50 mm. Hoechst refers to the dye used for nuclear staining.
Wild-type
Wild-type ( Fig. 6f-h ), which resulted in significantly reduced levels of cell death ( Fig. 6f-h ). However, cell death was not completely abolished, again suggesting that p75 may not be the only mediator of cell death induced by TrkA or TrkC. Also, the results obtained with embryos generated from the corresponding ES cells indicate that TrkA and TrkC can dominantly cause the death of all developing neurons, though p75 is not expressed at high levels in most CNS areas. Alternative candidates include the p75-related molecules NRH2, Troy and DR6, all members of the large tumour necrosis factor receptor family 38 . Additional work will also be required to explain why TrkB does not initiate the death process. We observed that in membrane fractions prepared from the corresponding ES-cellderived neurons, TrkB partitions differently from TrkA and TrkC (V.N. and Y.-A.B., manuscript in preparation).
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Discussion
The finding that TrkB, unlike TrkA and TrkC, does not trigger neuronal death suggests that in the developing CNS, mechanisms based on cellcell contact and synaptic transmission predominate over those involving diffusible ligands in controlling the survival of neurons. During the course of the evolution of the nervous system, the diversification of the Trk family seems to have accompanied the generation of epidermal placodes and the neural crest as transient structures at the origin of the peripheral nervous system. This view is consistent with the observation that the cephalochordate Amphioxus, which lacks a neural crest 39 , has only one Trk receptor 10 . It will be interesting to examine the role of this unique Trk receptor in Amphioxus where it is primarily expressed in neurons, both during development and in the adult 10 . In vertebrates, the progenitors of the peripheral nervous system migrate and divide extensively as single cells outside their epithelia of origin. TrkA and TrkC are both expressed at high levels by many peripheral nervous system neurons at the time of target innervation, and cell numbers can then be adjusted by creating a dependency for survival on local sources of neurotrophins restricted to the newly colonized territories.
The lack of death-inducing activity of TrkB does not imply that its activation by BDNF is not required to prevent neuronal death during the development of the peripheral nervous system. For example, BDNF deprivation causes substantial losses of cranial sensory neurons, and these neurons are known to require TrkB activation to survive 40 . However, mechanisms not based on TrkB expression are likely to predispose these neurons to die, including high levels of death-inducing receptors such as p75, NRH2 or TrkC, the latter being expressed at levels similar to TrkB in vestibular neurons, without any detectable survival role for its ligand NT3 (ref. 41 ). Likewise after axotomy or in culture, CNS neurons including motoneurons or retinal ganglion cells are rescued by the addition of BDNF 42 , but these neurons upregulate death-inducing molecules such as p75 following section of their axons 43 . Mice lacking BDNF fail to show significant losses of motoneurons or of retinal ganglion cells 8, 42, 44 . Beyond new insights in vertebrate nervous system development, our findings also suggest an explanation for the different prognoses associated with tumours derived from the neural crest, including neuroblastomas in particular. It has long been recognized that tumours arising from progenitors of the sympatho-adrenal lineage often spontaneously regress when expressing TrkA or TrkC (see ref. 45 for a review). By contrast, TrkB-expressing neuroblastomas have a significantly poorer prognosis. 
